Oragenics Inc (OGEN) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/oragenics_inc_orni_financial_n_strategic_swot_analysis_review_en.gif)
Oragenics Inc (OGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Oragenics Inc (Oragenics) focuses on designing of TerraCoV2, immunization product candidate to fight the novel coronavirus. The company is also focused on the development and commercialization of novel antibiotics against infectious diseases, other treatments for oral mucositis and healthcare associated infections (HAIs). The company's product candidates include OG716, an antibiotic candidate for treating HAIs; SMaRT Replacement Therapy, a painless treatment to prevent tooth decay; and LPT3-04, a naturally occurring chemical agent that promotes weight loss. It develops product candidates based on the mechanism action of Lantibiotics. The company has collaborations with National Institute of Allergy and Infectious Diseases, Adjuvance Technologies Inc, Precigen Inc, LPThera LLC and Aragen Bioscience for the development of its pipeline products. Oragenics is headquartered in Tampa, Florida, the US.
Oragenics Inc Key Recent Developments
May 03,2021: Oragenics Announce Changes in Management and Board of Directors
Mar 08,2021: Oragenics to Participate in Two Investment Conferences During March
Feb 12,2021: Oragenics Announces Recent Capital Raise and Warrant Exercises Totaling $21.9 Million and the Redemption of Its Series C Preferred Stock
Jan 14,2021: Oragenics issues letter to stockholders
Jul 10,2020: Oragenics provides update on SARS-CoV-2 (COVID-19) program
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Oragenics Inc (Oragenics) focuses on designing of TerraCoV2, immunization product candidate to fight the novel coronavirus. The company is also focused on the development and commercialization of novel antibiotics against infectious diseases, other treatments for oral mucositis and healthcare associated infections (HAIs). The company's product candidates include OG716, an antibiotic candidate for treating HAIs; SMaRT Replacement Therapy, a painless treatment to prevent tooth decay; and LPT3-04, a naturally occurring chemical agent that promotes weight loss. It develops product candidates based on the mechanism action of Lantibiotics. The company has collaborations with National Institute of Allergy and Infectious Diseases, Adjuvance Technologies Inc, Precigen Inc, LPThera LLC and Aragen Bioscience for the development of its pipeline products. Oragenics is headquartered in Tampa, Florida, the US.
Oragenics Inc Key Recent Developments
May 03,2021: Oragenics Announce Changes in Management and Board of Directors
Mar 08,2021: Oragenics to Participate in Two Investment Conferences During March
Feb 12,2021: Oragenics Announces Recent Capital Raise and Warrant Exercises Totaling $21.9 Million and the Redemption of Its Series C Preferred Stock
Jan 14,2021: Oragenics issues letter to stockholders
Jul 10,2020: Oragenics provides update on SARS-CoV-2 (COVID-19) program
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Oragenics Inc - Key Facts
Oragenics Inc - Key Employees
Oragenics Inc - Key Employee Biographies
Oragenics Inc - Major Products and Services
Oragenics Inc - History
Oragenics Inc - Company Statement
Oragenics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Oragenics Inc - Business Description
R&D Overview
Oragenics Inc - Corporate Strategy
Oragenics Inc - SWOT Analysis
SWOT Analysis - Overview
Oragenics Inc - Strengths
Oragenics Inc - Weaknesses
Oragenics Inc - Opportunities
Oragenics Inc - Threats
Oragenics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Oragenics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 03, 2021: Oragenics Announce Changes in Management and Board of Directors
Mar 08, 2021: Oragenics to Participate in Two Investment Conferences During March
Jan 14, 2021: Oragenics issues letter to stockholders
Jul 10, 2020: Oragenics provides update on SARS-CoV-2 (COVID-19) program
May 04, 2020: Oragenics announces new member of the board of directors
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Oragenics Inc - Key Facts
Oragenics Inc - Key Employees
Oragenics Inc - Key Employee Biographies
Oragenics Inc - Major Products and Services
Oragenics Inc - History
Oragenics Inc - Company Statement
Oragenics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Oragenics Inc - Business Description
R&D Overview
Oragenics Inc - Corporate Strategy
Oragenics Inc - SWOT Analysis
SWOT Analysis - Overview
Oragenics Inc - Strengths
Oragenics Inc - Weaknesses
Oragenics Inc - Opportunities
Oragenics Inc - Threats
Oragenics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Oragenics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 03, 2021: Oragenics Announce Changes in Management and Board of Directors
Mar 08, 2021: Oragenics to Participate in Two Investment Conferences During March
Jan 14, 2021: Oragenics issues letter to stockholders
Jul 10, 2020: Oragenics provides update on SARS-CoV-2 (COVID-19) program
May 04, 2020: Oragenics announces new member of the board of directors
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Oragenics Inc, Key Facts
Oragenics Inc, Key Employees
Oragenics Inc, Key Employee Biographies
Oragenics Inc, Major Products and Services
Oragenics Inc, History
Oragenics Inc, Other Locations
Oragenics Inc, Subsidiaries
Oragenics Inc, Key Competitors
Oragenics Inc, Ratios based on current share price
Oragenics Inc, Annual Ratios
Oragenics Inc, Annual Ratios (Cont...1)
Oragenics Inc, Interim Ratios
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Oragenics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Oragenics Inc, Key Facts
Oragenics Inc, Key Employees
Oragenics Inc, Key Employee Biographies
Oragenics Inc, Major Products and Services
Oragenics Inc, History
Oragenics Inc, Other Locations
Oragenics Inc, Subsidiaries
Oragenics Inc, Key Competitors
Oragenics Inc, Ratios based on current share price
Oragenics Inc, Annual Ratios
Oragenics Inc, Annual Ratios (Cont...1)
Oragenics Inc, Interim Ratios
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Oragenics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Oragenics Inc, Performance Chart (2016 - 2020)
Oragenics Inc, Ratio Charts
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oragenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Oragenics Inc, Performance Chart (2016 - 2020)
Oragenics Inc, Ratio Charts
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oragenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021